Therapeutic Strategies in Huntington's Disease.
- Author:
Ichiro KANAZAWA
1
Author Information
- Publication Type:Review
- Keywords: Huntington's Disease; Huntingtin; Cell therapy; Gene therapy; Aggregation; Autophagy; RNA interference
- MeSH: Atrophy; Autophagy; Cell- and Tissue-Based Therapy; Chorea; Genetic Therapy; Glutamine; Huntington Disease*; Intranuclear Inclusion Bodies; Neurons; RNA Interference; Stem Cell Transplantation; Transcranial Magnetic Stimulation; Wills
- From:Journal of Clinical Neurology 2006;2(4):213-224
- CountryRepublic of Korea
- Language:English
- Abstract: This article provides an overview of the therapeutic strategies, from ordinary classical drugs to the modern molecular strategy at experimental level, for Huntington's disease. The disease is characterized by choreic movements, psychiatric disorders, striatal atrophy with selective small neuronal loss, and autosomal dominant inheritance. The genetic abnormality is CAG expansion in huntingtin gene. Mutant huntingtin with abnormally long glutamine stretch aggregates and forms intranuclear inclusions. In this review, I summarize the results of previous trials from the following aspects; 1. symptomatic/palliative therapies including drugs, stereotaxic surgery and repetitive transcranial magnetic stimulation, 2. anti-degenerative therapies including anti-excitotoxicity, reversal of mitochondrial dysfunction and anti-apoptosis, 3. restorative/reparative therapies including neural trophic factors and tissue or stem cell transplantation, and 4. molecular targets in specific and radical therapies including inhibition of truncation of huntingtin, inhibition of aggregate formation, normalization of transcriptional dysregulation, enhancement of autophagic clearance of mutant huntingtin, and specific inhibition of huntingtin expression by sRNAi. Although the strategies mentioned in the latter two categories are mostly at laboratory level at present, we are pleased that one can discuss such "therapeutic strategies", a matter absolutely impossible before the causal gene of Huntington's disease was identified more than 10 years ago. It is also true, however, that some of the "therapeutic strategies" mentioned here would be found difficult to implement and abandoned in the future.
